Trial Profile
A Double-Blind, Placebo-Controlled Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2020
Price :
$35
*
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Alcoholic hepatitis
- Focus Adverse reactions; Therapeutic Use
- Acronyms TREAT
- 16 Jan 2020 Status changed from completed to discontinued.
- 06 Aug 2018 Status changed from recruiting to completed.
- 20 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jul 2018.